How many capmatinib tablets should be taken per day?

Capmatinib is a targeted drug used to treat MET gene mutation-positive non-small cell lung cancer (NSCLC). Therapeutic effectiveness and dosage depend on the patient's specific condition and other health factors. The recommended dose of capmatinib is usually determined by the physician based on the patient's weight, drug resistance, and severity of the disease. In general, the usual recommended dose for adult patients is 400 mg taken orally once daily. For most patients, this dose provides effective disease control and is well tolerated.

The usual dose of capmatinib is400mg, that is, one or two tablets taken once a day. Typically, capmatinib is taken in oral form and is recommended to be taken after a meal or on an empty stomach, but try to keep the dosage time consistent. Patients need to follow the correct way of taking medication according to the doctor's advice. Patients should avoid chewing or crushing tablets while taking the medicine, as this may affect the effectiveness and rate of absorption of the medicine. Following your doctor's dosage adjustment recommendations is crucial for the drug to be effective.

In some cases, doctors may adjust the capmatinib dose based on patient response or adverse effects. For example, if a patient experiences serious adverse effects, especially liver damage or lung complications, doctors may reduce the dose or suspend treatment for a period of time. Typically, if patients do not experience serious adverse reactions during treatment, they can continue to take capmatinib at their regular dose. For elderly patients or patients with poor liver and kidney function, the dosage may need to be specially adjusted to ensure the safety and effectiveness of the drug.

While taking capmatinib, patients need to undergo regular medical monitoring, including liver and kidney function tests, to ensure that the drug does not cause serious side effects. Especially in the first few weeks of treatment, patients should visit their doctor regularly and report any symptoms of discomfort, such as fatigue, jaundice, loss of appetite, etc. to their doctor. If the patient experiences weight loss, diarrhea, nausea or other discomfort while taking the medication, he or she should inform the doctor in time, and the doctor will adjust the treatment plan according to the patient's actual condition.

Reference materials:https://www.novartis.com/our-products/pipeline/capmatinib